CareLit · DOI-Nachweis · Pneumologie
ENLARGE Lung: First Interim Primary Cohort Data (n = 660) from a National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) after Prior Chemotherapy in Patients (pts) with Locally Advanced or Metastatic (Stage IIIB/IV) Squam…
DOI 10.1055/s-0039-1678137
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Sebastian, M Gröschel, S Gütz, H Schulz, K Kratz-Albers, H Müller-Huesmann, C Schumann
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
ENLARGE Lung: First Interim Primary Cohort Data (n = 660) from a National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) after Prior Chemotherapy in Patients (pts) with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous/Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Zitieren
Zitierempfehlung
M Sebastian, M Gröschel, S Gütz, H Schulz, K Kratz-Albers, H Müller-Huesmann, C Schumann (2019) ENLARGE Lung: First Interim Primary Cohort Data (n = 660) from a National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) after Prior Chemotherapy in Patients (pts) with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous/Non-squamous Non-Small Cell Lung Cancer (NSCLC). Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678137
Mit CareLit weiterarbeiten